Research Topics
| V J VerwaalSummaryAffiliation: The Netherlands Cancer Institute Country: The Netherlands Publications
| Collaborators
|
Detail Information
Publications
Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcomeVic J Verwaal
Department of Surgery, The Netherlands Cancer Institute and Antoni van Leeuwenhoeck Hospital, Amsterdam, The Netherlands
Ann Surg Oncol 11:375-9. 2004..This study evaluates the outcome of such recurrences after initial treatment by cytoreduction and HIPEC...
Specific genomic aberrations in primary colorectal cancer are associated with liver metastasesSjoerd C Bruin
Division of Experimental Therapy, Department of Pathology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands
BMC Cancer 10:662. 2010..Patterns of genomic aberrations in primary colorectal tumors may reveal a chromosomal signature for organ specific metastases...
Long-term survival of peritoneal carcinomatosis of colorectal originVic J Verwaal
Department of Surgery, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
Ann Surg Oncol 12:65-71. 2005..In The Netherlands Cancer Institute, this treatment has been performed since 1995. The long tradition of this treatment enabled us to study long-term survival in detail...
8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancerVic J Verwaal
Department of Surgery, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
Ann Surg Oncol 15:2426-32. 2008..This trial showed a positive result favoring the studied treatment. This trial has now been updated to a minimal follow-up of 6 years to show long-term results...
Detection and treatment of recurrent disease after cytoreduction and HIPECV J Verwaal
Department of Surgery, The Netherlands Cancer Institute, Amsterdam
Cancer Treat Res 134:419-24. 2007
Follow-up of patients treated by cytoreduction and chemotherapy for peritoneal carcinomatosis of colorectal originV J Verwaal
Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Eur J Surg Oncol 30:280-5. 2004..The aim of this study was to determine the value of medical history and physical examination, tumour marker testing, and CT-scanning in the follow-up of patients treated for peritoneal carcinomatosis of colorectal origin...
Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapyVic J Verwaal
Department of Surgery, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
J Surg Oncol 85:61-7. 2004..Cytoreduction with hyperthermic intra-peritoneal chemotherapy (HIPEC) is a treatment with a high morbidity. Optimal patients selection can possible reduce toxicity and complications...
Long-term results of cytoreduction and HIPEC followed by systemic chemotherapyVic J Verwaal
The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Cancer J 15:212-5. 2009..This treatment has been available for more than 10 years. Therefore, long-term results on survival and quality of life can now be studied. With these results, the true long-term benefits of this new management strategy can be determined...
Results of cytoreduction followed by HIPEC in carcinomatosis of colorectal originV J Verwaal
Department of Surgery, The Netherlands Cancer Institute, Amsterdam
Cancer Treat Res 134:291-301. 2007
Cytoreduction and HIPEC for peritoneal carcinomatosis from colorectal origin: the Amsterdam experienceV J Verwaal
The Netherlands Cancer Institute, Amsterdam, The Netherlands
Acta Chir Belg 106:283-4. 2006
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancerVic J Verwaal
Department of Surgery, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
J Clin Oncol 21:3737-43. 2003....
Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapyV J Verwaal
Departments of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Br J Surg 91:739-46. 2004..001). No other factor correlated with survival. CONCLUSION: The survival of patients with peritoneal carcinomatosis of colorectal origin is dominated by the extent of disease and the amount of residual tumour after cytoreduction...
Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei--a report of 103 proceduresR M Smeenk
Department of Surgery, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Eur J Surg Oncol 32:186-90. 2006....
Heat penetration in locally applied hyperthermia in the abdomen during intra-operative hyperthermic intraperitoneal chemotherapyS van Ruth
Department of Surgical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Anticancer Res 23:1501-8. 2003..The aim of this study was to evaluate heat penetration in the abdomen during 10 HIPEC procedures...
Quantitative intra-operative assessment of peritoneal carcinomatosis - a comparison of three prognostic toolsH A M Swellengrebel
Department of Surgical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
Eur J Surg Oncol 35:1078-84. 2009..We compared the predictive power of three intra-operative assessment tools of peritoneal involvement of colorectal cancer...
Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapyE de Bree
Department of Surgical Oncology, Antoni van Leeuwenhoek Hospital The Netherlands Cancer Unit, Amsterdam, The Netherlands
Eur J Surg Oncol 32:65-71. 2006..We studied whether poor survivors could be identified on preoperative computed tomography (CT), in order to avoid unnecessary surgery...
Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy for stage I malignant pleural mesotheliomaS van Ruth
Department of Surgical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Ann Surg Oncol 10:176-82. 2003..Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy is used to kill residual tumor cells on the surface of the thoracic cavity while having limited systemic side effects...
Appendiceal neoplasms and pseudomyxoma peritonei: a population based studyR M Smeenk
Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Eur J Surg Oncol 34:196-201. 2008..However it is not known exactly how often these neoplasms lead to PMP. The aim of this study is to investigate the incidence of both lesions and their relation...
Multidisciplinary discussion and management of rectal cancer: a population-based studyH A M Swellengrebel
Department of Gastroenterology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
World J Surg 35:2125-33. 2011..The purpose of the present study was to evaluate the value of discussing rectal cancer patients in a multidisciplinary team (MDT)...
Learning curve of combined modality treatment in peritoneal surface diseaseR M Smeenk
Department of Surgery, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Br J Surg 94:1408-14. 2007..Cytoreductive surgery with intraperitoneal chemotherapy has emerged as a new standard approach for peritoneal surface disease. This study investigated the learning curve of this combined modality treatment at a single institute...
Pseudomyxoma peritonei and the urinary tract: involvement and treatment related complicationsR M Smeenk
Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
J Surg Oncol 93:20-3. 2006..The combination of secondary involvement and previous pelvic surgery is an omen of treatment-related urologic complications, necessitating (surgical) re-interventions and further management in close collaboration with urologists...
Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: a prospective studyA L A Bloemendaal
Department of Surgery, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Eur J Surg Oncol 31:1145-51. 2005..CONCLUSION: The survival time of patients with peritoneal carcinomatosis of colorectal origin seems to be increased in patients treated by conventional surgery and systemic chemotherapy when compared to minimal treatment...
Pharmacokinetics of intraperitoneal mitomycin CS van Ruth
Department of Surgical Oncology, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands
Surg Oncol Clin N Am 12:771-80. 2003..Comparative analyses on MMC pharmacokinetics are difficult to perform because the diversity of treatment techniques. We recommend administration of MMC, divided in three drug additions, based on BSA...
Pseudomyxoma peritonei: a review of 62 casesS van Ruth
Department of Surgical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Eur J Surg Oncol 29:682-8. 2003..Pseudomyxoma peritonei (PMP) is a rare disease characterized by the abundance of mucus in the abdomen without extra-peritoneal growth...
Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapyS van Ruth
Department of Surgical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Ann Surg Oncol 9:961-7. 2002..9 (CA19.9) measurements in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)...
Pseudomyxoma peritoneiR M Smeenk
Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Cancer Treat Rev 33:138-45. 2007..This approach is currently carried out in many centers throughout the world with promising results and seems to win ground as the standard treatment approach...
Molecular alterations associated with liver metastases development in colorectal cancer patientsS C Bruin
Department of Surgery, Division of Experimental Therapy, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Br J Cancer 105:281-7. 2011..We evaluated whether chromosomal aberrations, mutations in the PI(3)K signalling pathway and the CpG-island methylator phenotype (CIMP) in primary colorectal tumours can predict liver metastases...
Toxicity and complications of preoperative chemoradiotherapy for locally advanced rectal cancerH A M Swellengrebel
Department of Gastroenterology and Hepatology, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Br J Surg 98:418-26. 2011..In this study acute toxicity and surgical complications were evaluated in patients with locally advanced rectal cancer following total mesorectal excision (TME) after preoperative chemoradiotherapy (CRT) with capecitabine...
Effect of preservation of the right gastro-epiploic artery on delayed gastric emptying after cytoreductive surgery and HIPEC: a randomized clinical trialD J Evers
Department of Surgery, The Netherlands Cancer Institute NKI AvL, Amsterdam, The Netherlands
Eur J Surg Oncol 37:162-7. 2011..The aim of this study was to investigate if preservation of the right gastro-epiploic artery (GEA) during standard omentectomy would have a positive effect on gastric emptying after CRS-HIPEC...
Lessons learnt from clinical trials in peritoneal surface oncology: colorectal carcinomatosisFrans A N Zoetmulder
The Netherlands Cancer Institute, Antoni van Leeuwenhoek Ziekenhuis, Amsterdam
Recent Results Cancer Res 169:99-103. 2007
Progression of pseudomyxoma peritonei after combined modality treatment: management and outcomeRobert M Smeenk
Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Ann Surg Oncol 14:493-9. 2007..The aim of this study was to determine the patterns of failure in patients who underwent such a procedure and to evaluate management and outcome of progressive disease...
Hyperthermic intraperitoneal chemotherapy added to the treatment of ovarian cancer. A review of achieved results and complicationsE Dovern
Department of Surgery, Catharina Hospital Eindhoven, The Netherlands
Eur J Gynaecol Oncol 31:256-61. 2010..More recently, the modality of intraperitoneal administration of chemotherapy under hyperthermic conditions (HIPEC) has been added. This review surveys the results of HIPEC added to CRS in ovarian cancer...
Pharmacokinetics of doxorubicin and cisplatin used in intraoperative hyperthermic intrathoracic chemotherapy after cytoreductive surgery for malignant pleural mesothelioma and pleural thymomaS van Ruth
Department of Surgical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam
Anticancer Drugs 14:57-65. 2003..We conclude that HITHOC with doxorubicin and cisplatin is relatively a safe procedure with the advantage of high intrathoracic cytostatic drug concentrations, while having limited systemic side effects...
Indication for oophorectomy during cytoreduction for intraperitoneal metastatic spread of colorectal or appendiceal originD J Evers
Department of Surgery, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands
Br J Surg 98:287-92. 2011..The incidence of ovarian metastases at the time of peritoneal carcinomatosis, and the influence of such metastases on survival after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), are unknown...
Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapyRobert M Smeenk
Department of Surgery, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Ann Surg 245:104-9. 2007..To evaluate the survival of patients with pseudomyxoma peritonei (PMP) treated by cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC), and to identify factors with prognostic value...
Population pharmacokinetics and pharmacodynamics of mitomycin during intraoperative hyperthermic intraperitoneal chemotherapySerge van Ruth
Department of Surgical Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Clin Pharmacokinet 43:131-43. 2004..The developed pharmacokinetic-pharmacodynamic model can be used to simulate different dosage schemes in order to optimise mitomycin administration during HIPEC...
A trial of consent procedures for future research with clinically derived biological samplesE Vermeulen
The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands
Br J Cancer 101:1505-12. 2009..The aims of this study were to determine which consent procedure patients prefer for use of stored tissue for research purposes and what the effects of consent procedures on actual consenting behaviour are...
Indication for oophorectomy during cytoreduction for intraperitoneal metastatic spread of colorectal or appendiceal originD J Evers
Department of Surgery, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands
Br J Surg 98:287-92. 2011..The incidence of ovarian metastases at the time of peritoneal carcinomatosis, and the influence of such metastases on survival after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), are unknown...
The eligibility for local-regional treatment of peritoneal surface malignancyVic J Verwaal
Department of Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands
J Surg Oncol 98:220-3. 2008..General conflicting points concerning the eligibility to the local-regional therapy were discussed and voted...
